• Rachael Gooberman-Hill, Claire Heathcote, Colette M Reid, Jeremy Horwood, Andrew D Beswick, Susan Williams, and Matthew J Ridd.
• School of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, UK. r.gooberman-hill@bristol.ac.uk
• Fam Pract. 2011 Feb 1; 28 (1): 102109102-9.

BackgroundChronic joint pain is common and is a leading cause of disability. Most chronic joint pain is managed in primary care. Opioid pain medication is one option for pain management, but research suggests that its use by general practitioners (GPs) may be suboptimal. There is a widespread perception that doctors' concerns about misuse and addiction limit use of opioids.ObjectivesTo explore GPs' opinions about opioids and decision-making processes when prescribing 'strong' opioids for chronic joint pain.MethodsQualitative semi-structured interviews were conducted with 27 GPs. Using thematic analysis methods, the data were coded and grouped into themes.ResultsGPs described a variety of prescribing habits for chronic joint pain. Opioids engendered strong opinions. GPs said that decisions about prescribing were based on careful assessment of patients' needs and their personal views about the management of adverse effects. Although addiction and misuse were discussed, there was limited concern about these issues. The overarching influence on prescribing decisions was GPs' previous experience, including previous outcomes and exposure to palliative care settings.ConclusionsGPs' prescribing decisions are primarily influenced by previous professional experience of opioids. Much existing literature stresses that opioids are not prescribed due to concerns about addiction or misuse, but our study indicates otherwise. Augmenting GPs' exposure to and experience of opioids may be key to providing better pain management for patients.

19 keywords...

hide…